{"id":"https://openalex.org/W3046922919","doi":"https://doi.org/10.1158/1557-3125.hippo19-b32","title":"Abstract B32: High-throughput chemical screening reveals YAP-mediated alterations in drug sensitivities","display_name":"Abstract B32: High-throughput chemical screening reveals YAP-mediated alterations in drug sensitivities","publication_year":2020,"publication_date":"2020-08-01","ids":{"openalex":"https://openalex.org/W3046922919","doi":"https://doi.org/10.1158/1557-3125.hippo19-b32","mag":"3046922919"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3125.hippo19-b32","doi":"https://doi.org/10.1158/1557-3125.hippo19-b32","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.hippo19-b32","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021563373","display_name":"Andrew J. Bondesson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J. Bondesson","raw_affiliation_strings":["1Graduate Program in Molecular and Cellular Biology, University of Washington, Seattle, WA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Graduate Program in Molecular and Cellular Biology, University of Washington, Seattle, WA,","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030289972","display_name":"Aya Miyaki","orcid":"https://orcid.org/0009-0008-6748-4595","observed_orcids":["https://orcid.org/0009-0008-6748-4595"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aya Miyaki","raw_affiliation_strings":["2Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA,","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063897872","display_name":"Stella Shin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stella Shin","raw_affiliation_strings":["2Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA,","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045917555","display_name":"Michele Ceribelli","orcid":"https://orcid.org/0000-0001-9857-9521","observed_orcids":["https://orcid.org/0000-0001-9857-9521"]},"institutions":[{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michele Ceribelli","raw_affiliation_strings":["3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, Bethesda, MD","institution_ids":["https://openalex.org/I4210148682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014278257","display_name":"Craig J. Thomas","orcid":"https://orcid.org/0000-0001-9386-9001","observed_orcids":["https://orcid.org/0000-0001-9386-9001"]},"institutions":[{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig J. Thomas","raw_affiliation_strings":["3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, Bethesda, MD","institution_ids":["https://openalex.org/I4210148682"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029487600","display_name":"Taran S. Gujral","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taran S. Gujral","raw_affiliation_strings":["2Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA,","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"8_Supplement","first_page":"B32","last_page":"B32"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12065","display_name":"Hippo pathway signaling and YAP/TAZ","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12065","display_name":"Hippo pathway signaling and YAP/TAZ","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12620","display_name":"Signaling Pathways in Disease","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/yap","display_name":"YAP","score":0.972000002861023},{"id":"https://openalex.org/keywords/hippo-signaling-pathway","display_name":"Hippo signaling pathway","score":0.949999988079071},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5839999914169312},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.8949999809265137},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9829999804496765},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.8299999833106995},{"id":"https://openalex.org/keywords/gemcitabine-sensitivity","display_name":"gemcitabine sensitivity","score":0.902999997138977},{"id":"https://openalex.org/keywords/high-throughput-compound-screening","display_name":"high-throughput compound screening","score":0.8149999976158142},{"id":"https://openalex.org/keywords/therapeutic-vulnerabilities","display_name":"therapeutic vulnerabilities","score":0.40400001406669617},{"id":"https://openalex.org/keywords/compensatory-signaling","display_name":"compensatory signaling","score":0.6330000162124634},{"id":"https://openalex.org/keywords/pi3k-akt-inhibitors","display_name":"PI3K/AKT inhibitors","score":0.7609999775886536},{"id":"https://openalex.org/keywords/lats1-2","display_name":"LATS1/2","score":0.6549999713897705},{"id":"https://openalex.org/keywords/stk11","display_name":"STK11","score":0.8560000061988831},{"id":"https://openalex.org/keywords/neurofibromatosis-type-2","display_name":"neurofibromatosis type 2","score":0.9679999947547913}],"concepts":[{"id":"https://openalex.org/C172512520","wikidata":"https://www.wikidata.org/wiki/Q5768379","display_name":"Hippo signaling pathway","level":3,"score":0.8468482494354248},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6885005235671997},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.5725367665290833},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.5585417151451111},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5098954439163208},{"id":"https://openalex.org/C2780219982","wikidata":"https://www.wikidata.org/wiki/Q17544238","display_name":"YAP1","level":4,"score":0.48136764764785767},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.47422361373901367},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.46923643350601196},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4253019392490387},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.39827823638916016},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38759639859199524},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.32384541630744934},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.25468164682388306},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2505185008049011}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3125.hippo19-b32","doi":"https://doi.org/10.1158/1557-3125.hippo19-b32","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.hippo19-b32","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2605515821","https://openalex.org/W3046994816","https://openalex.org/W4410192108","https://openalex.org/W2234973443","https://openalex.org/W4244880692","https://openalex.org/W2025119327","https://openalex.org/W4213333775","https://openalex.org/W2794817947","https://openalex.org/W7204000503","https://openalex.org/W4282945586"],"abstract_inverted_index":{"Abstract":[0],"The":[1,200],"Hippo":[2,24,52,77,417,456],"pathway":[3,25,111,343,418],"is":[4,400],"evolutionarily":[5],"conserved":[6],"and":[7,16,30,37,66,79,160,177,198,243,265,325,372,460],"plays":[8],"a":[9,94,134,282,340,392],"critical":[10],"role":[11,108,237],"in":[12,17,22,44,55,112,118,150,158,170,205,235,238,285,308,316,322,370,402,416,443],"determining":[13],"organ":[14],"size":[15],"tumorigenesis.":[18],"Aberrant":[19],"genetic":[20],"alterations":[21,442],"the":[23,110,139,148,171,450,455],"genes":[26,53],"including":[27,186],"LATS1/2,":[28],"NF2,":[29],"STK11,":[31],"as":[32,34,85,180,182,376],"well":[33,181],"increased":[35,56,129,387],"expression":[36],"activity":[38,389],"of":[39,49,51,59,72,145,164,188,210,250,256,271,296,449],"YAP":[40,81,130,226,278,334,388],"have":[41,161,230,312],"been":[42],"found":[43],"some":[45],"human":[46],"cancers.":[47,404],"Loss":[48],"function":[50,375],"results":[54,315],"nuclear":[57,189,333],"localization":[58],"YAP,":[60],"which":[61],"promotes":[62],"cell":[63,320,345],"proliferation,":[64],"migration,":[65],"invasion.":[67],"Despite":[68],"our":[69,102,232,361],"increasing":[70,239],"understanding":[71],"molecular":[73,394],"phenotypes":[74],"associated":[75],"with":[76,349,365],"aberration":[78],"excess":[80,277],"activity,":[82,131],"there":[83],"are":[84,153,363],"yet":[86],"no":[87],"FDA-approved":[88],"therapies":[89],"targeting":[90],"this":[91,151,354,398],"pathway,":[92],"representing":[93],"large,":[95],"unmet":[96],"patient":[97],"need.":[98],"Previous":[99],"work":[100,234],"from":[101],"lab":[103],"has":[104],"established":[105],"an":[106,377],"additional":[107],"for":[109,155,293,344,396,412],"altering":[113],"cellular":[114,184,266,286],"response":[115],"to":[116,241,260,288,357,380],"gemcitabine":[117,242],"pancreatic":[119,319],"cancer":[120,159],"(PNAS":[121],"2017).":[122],"To":[123],"uncover":[124],"therapeutic":[125,410],"vulnerabilities":[126],"caused":[127,275],"by":[128,276],"we":[132],"performed":[133],"quantitative,":[135],"high-throughput":[136],"screen":[137,201],"using":[138],"Mechanism":[140],"Interrogation":[141],"PlatE":[142],"(MIPE)":[143],"library":[144,152,173],"compounds.":[146],"All":[147],"drugs":[149,251],"relevant":[154],"clinical":[156],"use":[157],"known":[162],"mechanisms":[163,185],"action.":[165],"Annotated":[166],"gene":[167],"families":[168],"represented":[169],"MIPE":[172],"include":[174],"kinases,":[175],"GPCRs,":[176],"ion":[178],"channels":[179],"broad":[183],"modulators":[187],"receptor":[190],"transcription":[191],"factors,":[192],"lipid":[193],"metabolism,":[194],"histone":[195],"epigenetic":[196],"machinery,":[197],"apoptosis.":[199],"was":[202],"carried":[203],"out":[204,295],"twenty":[206],"1,536-well":[207],"plates":[208],"consisting":[209],"2,154":[211],"compounds":[212],"at":[213],"nine":[214],"different":[215],"doses":[216],"on":[217,253,302,454],"both":[218,323],"Panc02.13":[219],"cells":[220],"expressing":[221],"GFP":[222],"or":[223,273],"constitutively":[224],"active":[225],"(YAPS6A).":[227],"Preliminary":[228],"data":[229,362,384],"confirmed":[231],"previous":[233,366],"YAP\u2019s":[236],"sensitivity":[240],"several":[244,317],"other":[245,318],"chemotherapeutics.":[246],"Pathway":[247],"enrichment":[248],"analysis":[249,330],"based":[252],"similar":[254],"mechanism":[255,379,395],"action":[257],"allowed":[258],"us":[259],"identify":[261],"specific":[262],"signaling":[263,374],"nodes":[264],"processes":[267],"that":[268,332,368,386],"present":[269],"points":[270],"vulnerability":[272],"resistance":[274,287,356],"activity.":[279],"We":[280,311],"discovered":[281],"profound":[283],"increase":[284],"MEK":[289,298,358,381],"inhibitors.":[290,359],"AC50":[291],"values":[292],"seventeen":[294],"eighteen":[297],"inhibitors":[299,351],"tested":[300],"were":[301],"average":[303],"more":[304],"than":[305],"four-fold":[306],"higher":[307],"YAPS6A-expressing":[309],"cells.":[310],"validated":[313],"these":[314],"lines":[321],"2D":[324],"3D":[326],"spheroid":[327],"assays.":[328],"Molecular":[329],"revealed":[331],"causes":[335],"sustained":[336],"PI3K/AKT":[337,350,406],"activation,":[338],"providing":[339],"plausible":[341],"compensatory":[342],"survival.":[346],"Moreover,":[347],"treatment":[348],"can":[352],"abrogate":[353],"YAP-induced":[355],"Overall":[360],"consistent":[364],"findings":[367],"increases":[369],"PI3K":[371],"AKT":[373],"escape":[378,399],"inhibition.":[382],"Our":[383],"suggest":[385],"may":[390,407],"represent":[391],"distinct":[393],"how":[397],"accomplished":[401],"refractory":[403],"Cotargeting":[405],"thus":[408],"provide":[409],"options":[411],"patients":[413],"carrying":[414],"mutations":[415],"genes.":[419],"Citation":[420],"Format:":[421],"Andrew":[422],"J.":[423,432],"Bondesson,":[424],"Aya":[425],"Miyaki,":[426],"Stella":[427],"Shin,":[428],"Michele":[429],"Ceribelli,":[430],"Craig":[431],"Thomas,":[433],"Taran":[434],"S.":[435],"Gujral.":[436],"High-throughput":[437],"chemical":[438],"screening":[439],"reveals":[440],"YAP-mediated":[441],"drug":[444],"sensitivities":[445],"[abstract].":[446],"In:":[447],"Proceedings":[448],"AACR":[451],"Special":[452],"Conference":[453],"Pathway:":[457],"Signaling,":[458],"Cancer,":[459],"Beyond;":[461],"2019":[462],"May":[463],"8-11;":[464],"San":[465],"Diego,":[466],"CA.":[467],"Philadelphia":[468],"(PA):":[469],"AACR;":[470],"Mol":[471],"Cancer":[472],"Res":[473],"2020;18(8_Suppl):Abstract":[474],"nr":[475],"B32.":[476]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2020-08-10T00:00:00"}